Sponsor:
Massachusetts General Hospital
Code:
NCT06795529
Conditions
Metastatic Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Palliative Care Intervention, "TARGET-PC"
Enhanced Usual Care
Brief summary:
Conditions
Metastatic Breast Cancer
Study ID
NCT06795529
Start date
Oct 1, 2025
Status verified date
Nov, 2025
Completion date
Mar 31, 2030
Anticipated
Primary completion date
Oct 1, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
400 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
experimental: Palliative Care Intervention, "TARGET-PC"
active comparator: Enhanced Usual Care
Interventions
Palliative Care Intervention, "TARGET-PC"
Enhanced Usual Care
Primary outcome measure
Central contacts
Locations
Massachusetts General Hospital
Recruiting
Boston, Massachusetts, United States, 02465
Contacts
Principal Investigator:
Jennifer Temel, MD
Duke University
Recruiting
Durham, North Carolina, United States, 54677
Contacts
Principal Investigator:
Thomas Leblanc, MD
University of Pennsylvania
Recruiting
Philadelphia, Pennsylvania, United States, 46205
Contacts
Principal Investigator:
Pallavi Kumar, MD, MPH
Sponsor
Massachusetts General Hospital
Last update posted
Nov 18, 2025
Last verified
Nov, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2025-11-18.